Jan 20, 2021

American Society of Hematology Selects Ami Patel to Receive ASH Scholar Award

HCI physician-scientist Ami Patel, MD, has been selected by the American Society of Hematology (ASH) to receive a Scholar Award for her research in leukemia. ASH Scholar Awards are one of ASH’s most prestigious research award programs. They provide financial support to fellows and junior faculty who have dedicated their careers to advancing the field of hematology research as they transition from training programs to careers as independent investigators.

Jan 13, 2021

Talks with Docs: Robert Judson-Torres, Melanoma Researcher

“Any human disease is so complicated that in order to really have the best care for patients, as well as sort of pushing the envelope on research, you need experts in all of it,” says melanoma researcher Robert Judson-Torres, PhD. In this Talks with Docs video, he explains why he wanted to become a cancer researcher, what he hopes his melanoma research will accomplish, and why Indiana Jones is his inspiration.

Dec 18, 2020

Gertz and Oliver as Cancer Center Research Program Leaders

Huntsman Cancer Institute at the University of Utah announced Jay Gertz, PhD, and Trudy G. Oliver, PhD, have accepted invitations to serve as co-leaders of Huntsman Cancer Institute Comprehensive Cancer Center research programs. Gertz will serve alongside Jared Rutter, PhD, as co-leader of the Nuclear Control of Cell Growth and Differentiation Program. Oliver will serve alongside Sheri Holmen, PhD, as co-leader of the Cell Response and Regulation Program.

Dec 04, 2020

Fighting to Improve Outcomes in Gastrointestinal Cancers by Understanding Risk Factors and Related Chronic Diseases

Sheetal Hardikar, MBBS, PhD, MPH studies multiple aspects of gastrointestinal cancers, particularly cancers of the esophagus and colon. Over the last few years, she has focused her work on understanding the complex relationship between diabetes and cancer. The 5 For The Fight Fellowship will provide her a whole new set of resources to help accelerate her progress in improving outcomes for people with cancer.

Dec 03, 2020

Researchers Identify Promising Drug Combination for Melanoma

Researchers at Huntsman Cancer Institute at the University of Utah have identified a potential drug combination to treat uveal melanoma, a type of eye cancer. Lead author Amanda Truong, trainee in the McMahon Lab at HCI, explains uveal melanoma patients frequently have changes in genes called GNAQ and GNA11, which are key targets for these drugs. This study was published in the journal Clinical Cancer Research.

Nov 27, 2020

Fighting Melanoma and Other Cancers Using Immunotherapy

For Siwen Hu-Lieskovan, MD, PhD, it was the promise of immunotherapy—that is, harnessing the body’s own immune system to fight cancer—that inspired her to get into cancer research. Training under one of the pioneers of immunotherapy, she witnessed amazing survival stories of patients. The project Hu-Lieskovan proposed for the 5 For The Fight grant is to tackle the immune-related adverse events when adding different immunotherapies.

Nov 20, 2020

Fighting to Improve Cancer Outcomes with Diet and Exercise

Adriana Coletta was gearing up for a career in sports dietetics until she completed her dietetic internship. As part of a medical team, she fell in love with patient care but knew her passion was in exercise. She decided to dedicate her life to integrating the principles of nutrition and exercise to those she felt could really benefit and who might be unaware or not focused on those two elements at that time—cancer patients.

Nov 19, 2020

University of Utah to Speed Process of Bringing New Therapeutics to Patients

A new initiative aims to speed the process of bringing lifesaving medical discoveries made in University of Utah laboratories to new drugs and therapies for patients. The university’s Huntsman Cancer Institute, College of Pharmacy, and the Partners for Innovation, Ventures, Outreach & Technology Center have partnered to establish the University of Utah Therapeutics Accelerator Hub (U2TAH, or the Accelerator).